Investors Press Releases Jun 05 2023 Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis Read More May 25 2023 Tiziana Life Sciences to Host KOL Webinar on Foralumab in Non-Active Secondary Progressive Multiple Sclerosis (SPMS) Read More May 23 2023 Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform Read More btn News View All Events & Presentations Jan 09 2023 - Jan 11 2023 Jan 09 2023 - Jan 11 2023 Biotech Showcase Read More Dec 29 2022 Dec 29 2022 Annual General Meeting 2022 Read More Nov 10 2022 at 10:00 AM EST Nov 10 2022 at 10:00 AM EST Investor call Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2022 641.6 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2022 4.2 MB btn ARs View All Annual General Meeting Notice of Annual General Meeting December 2022 276.9 KB btn AGM View All Scientific Pipeline Progress Learn more × Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Jun 05 2023 Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis Read More
May 25 2023 Tiziana Life Sciences to Host KOL Webinar on Foralumab in Non-Active Secondary Progressive Multiple Sclerosis (SPMS) Read More
May 23 2023 Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform Read More